Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

The facts about Stemedica

Nature Biotechnology volume 27, page 1085 (2009)Cite this article

A Correspondence to this article was published on 01 December 2009

Access through your institution
Buy or subscribe

To the Editor:

The News Feature in the September issue by Jane Qiu1 entitled “Trading on Hope” highlights the lack of oversight in certain clinical centers now offering stem cell treatments. At Stemedica, we recognize and respect the role that research and approved clinical trials have in the advancement of the stem cell industry. However, as vice chairman & CEO of the company, I was extremely concerned to find references within Qiu's article about our company. These references are inaccurate and potentially damaging to Stemedica's image within the regulatory, medical and investment communities and need to be corrected.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Qiu, J. Nat. Biotechnol. 27, 790–792 (2009).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Stemedica Cell Technologies, Inc., San Diego, California, USA

    Maynard A Howe

Authors
  1. Maynard A Howe
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Maynard A Howe.

Ethics declarations

Competing interests

As CEO and vice chairman of Stemedica, M.A.H. represents the vested interests of the company with a desire to present its point of view on a fair, but exclusive, basis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Howe, M. The facts about Stemedica. Nat Biotechnol 27, 1085 (2009). https://doi.org/10.1038/nbt1209-1085a

Download citation

  • Issue date:

  • DOI: https://doi.org/10.1038/nbt1209-1085a

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing